INS and COVID-19: Moreover, the comparable insulin requirements in COVID‐19 and non‐COVID‐19 viral pneumonitis when severity of illness and pre‐existing diabetes are accounted for argue against a direct action of SARS‐CoV‐2 on the pancreatic β‐cell as the likely cause of hyperglycaemia in COVID‐19, as has been suggested previously.6